Contact
searchSearch
HMP Global

Transplant Topic Center

Featured Article

News
Immunosuppressants After Solid Organ Transplant Carry Nutritional Implications
07/17/2024
Jolynn Tumolo
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid...
07/17/2024
Pharmacy Learning Network
News
Immunosuppressant Recalled
05/30/2024
Jolynn Tumolo
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
05/30/2024
Pharmacy Learning Network
News
Pharmacies Are Turning Away Immunocompromised Patients Seeking Fourth COVID-19 Shot
01/26/2022
Liz Szabo
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from...
01/26/2022
Pharmacy Learning Network
News
Alemtuzumab-Based Induction Promising for Kidney Transplant
08/17/2014
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard...
08/17/2014
Pharmacy Learning Network

News
Immunosuppressants After Solid Organ Transplant Carry Nutritional Implications
07/17/2024
Jolynn Tumolo
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid...
07/17/2024
Pharmacy Learning Network
News
Immunosuppressant Recalled
05/30/2024
Jolynn Tumolo
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
05/30/2024
Pharmacy Learning Network
News
Pharmacies Are Turning Away Immunocompromised Patients Seeking Fourth COVID-19 Shot
01/26/2022
Liz Szabo
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from...
01/26/2022
Pharmacy Learning Network
News
Alemtuzumab-Based Induction Promising for Kidney Transplant
08/17/2014
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard...
08/17/2014
Pharmacy Learning Network
News
FDA Issues Class II Recall for Peritoneal Dialysis Solutions Due to Potential Sterility Breach
05/07/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Fresenius DELFLEX peritoneal dialysis solutions due to potential bag leaks compromising sterility, affecting more than 80 000 units used in renal care.
The US Food and Drug Administration (FDA) has issued a Class II recall for Fresenius DELFLEX peritoneal dialysis solutions due to potential bag leaks compromising sterility, affecting more than 80 000 units used in renal care.
The US Food and Drug...
05/07/2026
Pharmacy Learning Network
News
Lubricant Eye Drops Under Class II Recall for Sterility Concerns
05/07/2026
Hannah Musick
A class II recall has been issued for FRESHKOTE Lubricant Eye Drops due to sterility assurance concerns, affecting more than 50 000 units used for dry eye relief.
A class II recall has been issued for FRESHKOTE Lubricant Eye Drops due to sterility assurance concerns, affecting more than 50 000 units used for dry eye relief.
A class II recall has been...
05/07/2026
Pharmacy Learning Network
News
Buspirone Tablets Recalled for Subpotency
05/07/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class III recall for buspirone tablets due to subpotency, potentially affecting treatment effectiveness.
The US Food and Drug Administration (FDA) has issued a Class III recall for buspirone tablets due to subpotency, potentially affecting treatment effectiveness.
The US Food and Drug...
05/07/2026
Pharmacy Learning Network
PharmLaw
North Carolina Reaches $11 Million EpiPen Settlement Over Pricing Practices
05/06/2026
Grace Taylor, MS, MA
North Carolina secured an $11 million settlement with Mylan over alleged EpiPen pricing and rebate practices that impacted Medicaid and state health plan costs.
North Carolina secured an $11 million settlement with Mylan over alleged EpiPen pricing and rebate practices that impacted Medicaid and state health plan costs.
North Carolina secured an $11...
05/06/2026
Pharmacy Learning Network
PharmLaw
Purdue Pharma Sentenced in Federal Opioid Case, Finalizing Fraud and Kickback Conspiracy Resolution
04/29/2026
Grace Taylor, MS, MA
Purdue Pharma’s federal sentencing finalizes a landmark opioid case involving fraud and kickback conspiracies, with lasting compliance implications for the pharmaceutical supply chain.
Purdue Pharma’s federal sentencing finalizes a landmark opioid case involving fraud and kickback conspiracies, with lasting compliance implications for the pharmaceutical supply chain.
Purdue Pharma’s federal...
04/29/2026
Pharmacy Learning Network
News
Memantine Hydrochloride Capsules Recalled for Failed Dissolution Specifications
04/23/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for memantine hydrochloride capsules due to failure to meet dissolution specifications.
The US Food and Drug Administration (FDA) has issued a Class II recall for memantine hydrochloride capsules due to failure to meet dissolution specifications.
The US Food and Drug...
04/23/2026
Pharmacy Learning Network
News
Semaglutide-Glycine-Cyanocobalamin Injectables Recalled for Lack of Sterility Assurance
04/23/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for semaglutide-glycine-cyanocobalamin injectable due to sterility assurance concerns, affecting 91 units.
The US Food and Drug Administration (FDA) has issued a Class II recall for semaglutide-glycine-cyanocobalamin injectable due to sterility assurance concerns, affecting 91 units.
The US Food and Drug...
04/23/2026
Pharmacy Learning Network
News
Essential Calming Skin Gel Recalled for Subpotent Drug
04/23/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for Essential Calming Skin Gel due to subpotent drug, affecting nearly 300 units.
The US Food and Drug Administration (FDA) has issued a Class III recall for Essential Calming Skin Gel due to subpotent drug, affecting nearly 300 units.
The US Food and Drug...
04/23/2026
Pharmacy Learning Network
PharmLaw
Executive Order Targets Accelerated Development and Access Pathways for Psychedelic Therapies in Mental Health
04/21/2026
Hannah Musick
A new executive order directs federal agencies to accelerate the development, review, and potential patient access to investigational psychedelic therapies for serious mental illness, signaling a shift in regulatory and research priorities...
A new executive order directs federal agencies to accelerate the development, review, and potential patient access to investigational psychedelic therapies for serious mental illness, signaling a shift in regulatory and research priorities...
A new executive order directs...
04/21/2026
Pharmacy Learning Network
News
Albuterol Sulfate Inhalation Solution Recalled for Illegible Labeling
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for albuterol sulfate inhalation solution due to illegible labeling, affecting more than 146 000 unit-dose vials used in respiratory care.
The US Food and Drug Administration (FDA) has issued a Class II recall for albuterol sulfate inhalation solution due to illegible labeling, affecting more than 146 000 unit-dose vials used in respiratory care.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network

What's New?

News
Immunosuppressants After Solid Organ Transplant Carry Nutritional Implications
07/17/2024
Jolynn Tumolo
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid...
07/17/2024
Pharmacy Learning Network
News
Immunosuppressant Recalled
05/30/2024
Jolynn Tumolo
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
05/30/2024
Pharmacy Learning Network
News
Pharmacies Are Turning Away Immunocompromised Patients Seeking Fourth COVID-19 Shot
01/26/2022
Liz Szabo
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from...
01/26/2022
Pharmacy Learning Network
News
Alemtuzumab-Based Induction Promising for Kidney Transplant
08/17/2014
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard...
08/17/2014
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use